We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Continuous Glucose Monitoring System in Intensive Care Unit

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01995994
First Posted: November 27, 2013
Last Update Posted: May 21, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Jin-Tae Kim, Seoul National University Hospital
  Purpose
To assess the accuracy, safety, and influence of sampling site of Real-time continuous glucose monitoring system (Medtronic Guardian).

Condition
Diabetic Blood Glucose Monitoring

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Continuous Glucose Monitoring System in Intensive Care Unit - Preliminary Study Evaluating Accuracy

Resource links provided by NLM:


Further study details as provided by Jin-Tae Kim, Seoul National University Hospital:

Primary Outcome Measures:
  • Difference between finger stick blood glucose and real-time continuous glucose monitoring [ Time Frame: 72 hours ]

Secondary Outcome Measures:
  • Measurement error of real-time continuous glucose monitoring [ Time Frame: 72 hours ]

Enrollment: 23
Study Start Date: June 2012
Study Completion Date: February 2014
Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients planned to stay in intensive care units longer than 72 hours
Criteria

Inclusion Criteria:

  • Older than 18 years old
  • Staying in intensive care units longer than 72 hours

Exclusion Criteria:

  • Skin disease
  • DIC
  • Immune suppressed patients
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01995994


Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Jin-Tae Kim, MD. PhD. Seoul National University Hospital
  More Information

Responsible Party: Jin-Tae Kim, Assistant Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01995994     History of Changes
Other Study ID Numbers: D-1203-106-404
First Submitted: November 21, 2013
First Posted: November 27, 2013
Last Update Posted: May 21, 2015
Last Verified: November 2013